Decreased endogenous antioxidant enzymatic status in essential hypertension

Journal of Human Hypertension

Volumn 14, Issue 6, 2000, Pages 343-345

  Pedro Botet, J ^a   Covas, M I ^b   Martin S ^b   Rubies Prat J ^b  

^a HOSPITAL DEL MAR   (Spain)

^b NONE

Author keywords

Antioxidant enzymes; Glutathione peroxidase; Superoxide dismutase

Indexed keywords

GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE;

EID: 0033933231     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001034     Document Type: Article

References (13)

1. Arnal JF, Michel JB, Harrison DG. Nitric oxide in the pathogenesis of hypertension. Curr Opin Nephrol Hypertens 1995; 4: 182-188.
2. Chobanian AV, Alexander RW. Exacerbation of atherosclerosis by hypertension: potential mechanisms and clinical implications. Arch Intern Med 1996; 156: 1952-1956.
3. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997; 96: 3264-3265.
4. Maggi E et al. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J Hypertens 1995; 13: 129-138.
5. Kumar KV, Das UM. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993; 19: 59-66.
6. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-1828.
7. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 241-244.
8. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 48-69.
9. Jun T, Ke-yan F, Catalano M. Increased superoxide anion production in humans: a possible mechanism for the pathogenesis of hypertension. J Hum Hypertens 1996; 10: 305-309.
10. Russo C et al. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998; 16: 1267-1271.
11. Forte P et al. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349: 837-842.
12. Lacy F, O'Connor DT, Schmid-Schönbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998; 16: 291-303.
13. Nakazono K et al. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 1991; 88: 10045-10048.